Vimupat tablets 50mg, containing Lacosamide, are manufactured by UCB Japan. Lacosamide is an antiepileptic drug used to treat partial-onset seizures in adults and children 4 years of age or older, and as adjunctive therapy for primary generalized tonic-clonic seizures. YJ code: 1139015F1027, Standard: 50mg 1 tablet.
Vimupat tablets 50mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
